Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-07-26
2005-07-26
Duffy, Patricia A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S190100, C424S185100, C424S184100, C536S023100, C536S023700, C435S069700, C435S069300, C435S069100, C530S300000, C530S350000
Reexamination Certificate
active
06921536
ABSTRACT:
The present invention relates i.a. to nucleic acid sequences encoding novelLawsonia intracellularisproteins. It furthermore relates to DNA fragments, recombinant DNA molecules and live recombinant carriers comprising these sequences. Also it relates to host cells comprising such nucleic acid sequences, DNA fragments, recombinant DNA molecules and live recombinant carriers. Moreover, the invention relates to proteins encoded by these nucleotide sequences. The invention also relates to vaccines for combatingLawsonia intracellularisinfections and methods for the preparation thereof. Finally the invention relates to diagnostic tests for the detection ofLawsonia intracellularisDNA, the detection ofLawsonia intracellularisantigens and of antibodies againstLawsonia intracellularis.
REFERENCES:
patent: 5610059 (1997-03-01), Joens et al.
patent: 5714375 (1998-02-01), Knittel et al.
patent: 5885823 (1999-03-01), Knittel et al.
patent: 2001169787 (1999-10-01), None
patent: 9304163 (1993-03-01), None
patent: 9639629 (1996-12-01), None
patent: 97 20050 (1997-06-01), None
patent: 0069903 (1999-05-01), None
patent: 0069904 (1999-05-01), None
patent: 0069906 (1999-05-01), None
patent: 00 69905 (2000-11-01), None
McOrist, S., Biod, R. and Lawson, G. H. K. 1989. Infect. Immun. 57: 957-962.
Smith et al 2000Infection and Immunity, Dec. 2000, pp. 6737-6743, vol. 68, No. 12.
Ellis, R.W. (Chapter 29 of “VACCINES” Plotkin, 5.A. et al. (eds) published by W. B. Saunders company (Philadelphia) in 1988, especially p. 571.
Rudinger et al, in “Peptide Hormones”, edited by Parsons, J.A., University Park Press, Jun. 1976, p. 6.
Burgess et al., The Journal of Cell Biology, 111:2129-2138, 1990.
Lazar et al., Molecular and Cellular Biology, 8(3): 1247-1252, 1988.
Jobling et al. (Mol. Microbiol, 1991, 5(7): 1755-67.
McCluskey et al, Infect Immun Jun. 2002; 70(6): 2899-907.
McOrist, S., et al: “Infection and Immunity.” vol. 61, (1993) No. 10, 5237-5244.
McOrist, S., et al: “Infection and Immunity.” vol. 60, (1992) No. 10, 4184-4191.
Herrick, J.B.: “Large Anim. Pract.” vol. 19, (1998) No. 6, 15.
Lawson, G.H. et al: “Vet. Rec.” vol. 107, (1980) No. 18, 424-425.
Holyoake, P.K., et al: “J. Clin. Microbiol.” vol. 32, (1994) No. 8, 1980-1985.
Database Swall 'Online!, Oct. 1, 2000, retrieved from EBI Database accession No. Q9KQE0.
Database Swall 'Online!, May 1, 1999, retrieved from EBI Database accession No. Q9ZCH2.
Kim J et al: Immunohistochemistry and Polymerase Chain Reaction for the Detection ofLawsonia intracellularisin Porcine Intentinal Tissues with Proliferative Enteropathy; Journal of Veterinary Medical Science; vol. 7, No. 62, Jul. 2000, pp. 771-773.
Dale C Jane H et al: “Identification and sequencing of the groE operon and flanking genes ofLawsonia intracellularis: Use in phylogeny”, Microbiology, Society for General Microbiology, Reading, GB, vol. 144, No. 8, Aug. 1998, pp. 2073-2084.
Jacobs Antonius Arnoldus Christiaan
Vermeij Paul
Akzo Nobel N.V.
Baskar Padma
Blackstone William H.
Duffy Patricia A.
LandOfFree
Lawsonia intracellularis vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lawsonia intracellularis vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lawsonia intracellularis vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3375958